- Details
- Description
Strength:
200 mg
Composition:
Capmatinib 200 mg
Treatment:
Used for the treatment of certain types of non-small cell lung cancer (NSCLC) with specific MET alterations.
Form:
Tablet
Brand:
Cabani
Quantity Unit:
Tablets
Manufacturer:
Ziska Pharmaceuticals Limited
Cabani 200 contains Capmatinib 200 mg, a targeted anticancer medicine known as a MET inhibitor. It is used for the treatment of certain types of non-small cell lung cancer (NSCLC), particularly cancers with specific MET alterations. Capmatinib works by blocking abnormal MET signaling that can promote the growth and spread of cancer cells. Cabani 200 is a prescription medicine and should be used under the supervision of a qualified healthcare professional.
